Trial Outcomes & Findings for Designing an Implementation Strategy for Lung Screening and Smoking Cessation Treatment in Community Health Centers (NCT NCT05447897)

Results Overview

Feasibility of Intervention Measure, 5-point Likert scales (range 1-5), higher values reflect favorable outcomes

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

9 participants

Primary outcome timeframe

End of study, up to 16 weeks

Results posted on

2024-04-16

Participant Flow

Participant milestones

Participant milestones
Measure	Stakeholder Advisory Group To co-design an implementation strategy that targets critical components in the delivery of SCT or LCS services for patients who smoke. Convene a stakeholder advisory group (CHC providers, quality improvement specialists, community engagement staff, and specialty providers) to review the results of the literature review and quantitative analysis of deidentified data in order to select a set of implementation strategies from a menu of strategies to implement. The team will meet with the stakeholder advisory group four times for 1-2 hours each. Qualitative Group Interviews: One time interview, 60-90 minutes Stakeholder advisory group: The team will meet with the stakeholder advisory group five to six times for 0.5-1 hours each
Overall Study STARTED	9
Overall Study COMPLETED	7
Overall Study NOT COMPLETED	2

Reasons for withdrawal

Reasons for withdrawal
Measure	Stakeholder Advisory Group To co-design an implementation strategy that targets critical components in the delivery of SCT or LCS services for patients who smoke. Convene a stakeholder advisory group (CHC providers, quality improvement specialists, community engagement staff, and specialty providers) to review the results of the literature review and quantitative analysis of deidentified data in order to select a set of implementation strategies from a menu of strategies to implement. The team will meet with the stakeholder advisory group four times for 1-2 hours each. Qualitative Group Interviews: One time interview, 60-90 minutes Stakeholder advisory group: The team will meet with the stakeholder advisory group five to six times for 0.5-1 hours each
Overall Study Did not participate in survey	2

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure	Stakeholder Advisory Group n=8 Participants To co-design an implementation strategy that targets critical components in the delivery of SCT or LCS services for patients who smoke. Convene a stakeholder advisory group (CHC providers, quality improvement specialists, community engagement staff, and specialty providers) to review the results of the literature review and quantitative analysis of deidentified data in order to select a set of implementation strategies from a menu of strategies to implement. The team will meet with the stakeholder advisory group five to six times for 0.5-1 hours each. Qualitative Group Interviews: One time interview, 60-90 minutes Stakeholder advisory group: The team will meet with the stakeholder advisory group five to six times for 0.5-1 hours each
Age, Categorical <=18 years	0 Participants n=8 Participants
Age, Categorical Between 18 and 65 years	8 Participants n=8 Participants
Age, Categorical >=65 years	0 Participants n=8 Participants
Sex: Female, Male Female	7 Participants n=8 Participants
Sex: Female, Male Male	1 Participants n=8 Participants
Region of Enrollment United States	8 participants n=8 Participants

PRIMARY outcome

Timeframe: End of study, up to 16 weeks

Feasibility of Intervention Measure, 5-point Likert scales (range 1-5), higher values reflect favorable outcomes

Outcome measures

Outcome measures
Measure	Stakeholder Advisory Group n=7 Participants To co-design an implementation strategy that targets critical components in the delivery of SCT or LCS services for patients who smoke. Convene a stakeholder advisory group (CHC providers, quality improvement specialists, community engagement staff, and specialty providers) to review the results of the literature review and quantitative analysis of deidentified data in order to select a set of implementation strategies from a menu of strategies to implement. The team will meet with the stakeholder advisory group five to six times for 0.5-1 hours each. Qualitative Group Interviews: One time interview, 60-90 minutes Stakeholder advisory group: The team will meet with the stakeholder advisory group five to six times for 0.5-1 hours each
Feasibility of Intervention Measure	4 units on a scale Interval 3.25 to 5.0

SECONDARY outcome

Timeframe: End of study, up to 16 weeks

Acceptability of Intervention Measure, 5-point Likert scales (range 1-5), higher values reflect favorable outcomes

Outcome measures

Outcome measures
Measure	Stakeholder Advisory Group n=7 Participants To co-design an implementation strategy that targets critical components in the delivery of SCT or LCS services for patients who smoke. Convene a stakeholder advisory group (CHC providers, quality improvement specialists, community engagement staff, and specialty providers) to review the results of the literature review and quantitative analysis of deidentified data in order to select a set of implementation strategies from a menu of strategies to implement. The team will meet with the stakeholder advisory group five to six times for 0.5-1 hours each. Qualitative Group Interviews: One time interview, 60-90 minutes Stakeholder advisory group: The team will meet with the stakeholder advisory group five to six times for 0.5-1 hours each
Acceptability of Intervention Measure	4 units on a scale Interval 4.0 to 5.0

SECONDARY outcome

Timeframe: End of study, up to 16 weeks

Intervention appropriateness measure, 5-point Likert scales (range 1-5), higher values reflect favorable outcomes

Outcome measures

Outcome measures
Measure	Stakeholder Advisory Group n=7 Participants To co-design an implementation strategy that targets critical components in the delivery of SCT or LCS services for patients who smoke. Convene a stakeholder advisory group (CHC providers, quality improvement specialists, community engagement staff, and specialty providers) to review the results of the literature review and quantitative analysis of deidentified data in order to select a set of implementation strategies from a menu of strategies to implement. The team will meet with the stakeholder advisory group five to six times for 0.5-1 hours each. Qualitative Group Interviews: One time interview, 60-90 minutes Stakeholder advisory group: The team will meet with the stakeholder advisory group five to six times for 0.5-1 hours each
Intervention Appropriateness Measure	4 units on a scale Interval 4.0 to 5.0

Adverse Events

Stakeholder Advisory Group

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Gina Kruse, PI

General Internal Medicine, University of Colorado School of

Phone: 303-724-4811

Email: [email protected]

Results disclosure agreements

Principal investigator is a sponsor employee
Publication restrictions are in place